Prentiss Smith & Co. Inc. Sells 586 Shares of Agilent Technologies, Inc. (NYSE:A)

Prentiss Smith & Co. Inc. trimmed its position in shares of Agilent Technologies, Inc. (NYSE:A) by 3.5% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 16,054 shares of the medical research company’s stock after selling 586 shares during the quarter. Agilent Technologies makes up about 1.5% of Prentiss Smith & Co. Inc.’s portfolio, making the stock its 26th biggest position. Prentiss Smith & Co. Inc.’s holdings in Agilent Technologies were worth $2,384,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently added to or reduced their stakes in the company. Western Pacific Wealth Management LP raised its holdings in shares of Agilent Technologies by 18.9% in the 1st quarter. Western Pacific Wealth Management LP now owns 440 shares of the medical research company’s stock valued at $64,000 after purchasing an additional 70 shares in the last quarter. Ballentine Partners LLC raised its position in shares of Agilent Technologies by 2.5% in the 1st quarter. Ballentine Partners LLC now owns 2,963 shares of the medical research company’s stock valued at $431,000 after purchasing an additional 73 shares during the last quarter. Haverford Trust Co boosted its stake in Agilent Technologies by 1.7% in the 1st quarter. Haverford Trust Co now owns 4,423 shares of the medical research company’s stock worth $644,000 after purchasing an additional 74 shares in the last quarter. Menard Financial Group LLC grew its position in Agilent Technologies by 1.6% during the 2nd quarter. Menard Financial Group LLC now owns 4,845 shares of the medical research company’s stock worth $628,000 after purchasing an additional 77 shares during the last quarter. Finally, Global Retirement Partners LLC increased its stake in Agilent Technologies by 3.2% during the 3rd quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company’s stock valued at $382,000 after purchasing an additional 79 shares in the last quarter. 87.42% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A has been the topic of a number of research analyst reports. UBS Group boosted their price objective on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Citigroup raised their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Barclays boosted their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a research note on Tuesday, October 15th. TD Cowen increased their price target on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Finally, Wells Fargo & Company initiated coverage on shares of Agilent Technologies in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price target on the stock. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $144.36.

Agilent Technologies Stock Down 1.5 %

Shares of NYSE:A traded down $2.06 during trading on Monday, hitting $136.77. The company’s stock had a trading volume of 313,714 shares, compared to its average volume of 1,682,754. The company has a market capitalization of $39.90 billion, a PE ratio of 32.82, a P/E/G ratio of 6.96 and a beta of 1.05. Agilent Technologies, Inc. has a fifty-two week low of $96.80 and a fifty-two week high of $155.35. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. The business has a 50 day moving average price of $141.02 and a two-hundred day moving average price of $138.73.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same period last year, the firm earned $1.43 EPS. The company’s quarterly revenue was down 5.6% compared to the same quarter last year. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st will be paid a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date is Tuesday, October 1st. Agilent Technologies’s payout ratio is currently 22.22%.

Insider Buying and Selling

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the sale, the chief executive officer now owns 24,118 shares in the company, valued at $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 13,953 shares of company stock worth $2,013,630. 0.33% of the stock is owned by corporate insiders.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.